About Synergo

About company

Synergo develops and provides a radiofrequency induced thermo-chemotherapy for the treatment of invasive cancer. Synergo focuses on minimally-invasive therapies providing benefits for patients and healthcare systems. Synergo's technology is based on homogenous RF radiation of the bladder in combination with chemotherapeutic instillation. Synergo is headquartered in Amstelveen, The Netherlands.